CLINICAL_TRIALS
trial_result
· 2007-01-26
Clinical Trial Update: Open Label Phase III Duloxetine Study for Stress Urinary Incontinence [Phase 3]
Summary
Open-label Phase III trial of duloxetine for stress urinary incontinence has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Urinary Incontinence Stress | Phase 3 | Status: COMPLETED